<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63077">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02284750</url>
  </required_header>
  <id_info>
    <org_study_id>NFH20141029</org_study_id>
    <nct_id>NCT02284750</nct_id>
  </id_info>
  <brief_title>Two-stent vs Provisional Stenting Techniques for Patients With Complex Coronary Bifurcation Lesions</brief_title>
  <acronym>DEFINITION-2</acronym>
  <official_title>A Prospective, Multi-center, Randomized Trial Comparing Two-stent With Provisional Stenting Techniques for Patients With Complex Coronary Bifurcation Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nanjing First Hospital, Nanjing Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nanjing First Hospital, Nanjing Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to establish the optimal strategy for stenting in coronary
      bifurcation lesion.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current study is designed as a multicenter, randomized and prospective study aiming to
      compare the effect of two-stenting and simple stenting techniques in patients with complex
      bifurcation lesions. Based on the previous studies, the rate of 1-year target lesion failure
      events was around 25% after PCI with provisional stenting. And our previous data showed that
      this event at 12-month after DK crush procedure was 15%. Considering the lost to follow-up,
      it is anticipated that up to 660 patients will be enrolled in the trial. All patients will
      have repeat angiography at 13 months, with clinical follow-up to 5 years.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>No masking</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target lesion failure</measure>
    <time_frame>12 months</time_frame>
    <description>Combined end point of: cardiac death, target-vessel myocardial infarction (MI), or ischemia-driven target lesion revascularization (TLR).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target lesion failure</measure>
    <time_frame>30 days</time_frame>
    <description>Combined end point of: cardiac death, target-vessel myocardial infarction (MI), or ischemia-driven target lesion revascularization (TLR).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularisation</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularisation</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularisation</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularisation</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>In-stent restenosis</measure>
    <time_frame>13 months</time_frame>
    <description>In-stent restenosis was defined as ≥50% diameter stenosis at the follow-up angiogram.</description>
  </other_outcome>
  <other_outcome>
    <measure>Late lumen loss</measure>
    <time_frame>13 months</time_frame>
    <description>The late lumen loss was defined as the difference between post- and follow-up minimal lumen diameter (MLD)</description>
  </other_outcome>
  <other_outcome>
    <measure>Acute gain</measure>
    <time_frame>Intraoperative</time_frame>
    <description>The acute gain was defined as the difference between post- and preprocedural minimal lumen diameter (MLD)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">660</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Two-stenting technique</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous coronary intervention with DK crush, or culotte, or provisional T stenting technique</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Simple stenting</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Percutaneous coronary intervention with simple stenting technique</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Two-stenting technique</intervention_name>
    <arm_group_label>Two-stenting technique</arm_group_label>
    <other_name>DK crush, culotte, provisional T stenting</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Simple stenting technique</intervention_name>
    <description>Stenting of the side branch in the simple stenting group was required if TIMI flow was &lt;3, or presence of type B dissection or greater after kissing balloon inflation.</description>
    <arm_group_label>Simple stenting</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous Coronary Intervention</intervention_name>
    <arm_group_label>Two-stenting technique</arm_group_label>
    <arm_group_label>Simple stenting</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Provision of informed consent prior to any study specific procedures;

          -  Men and women 18 years and older;.

          -  Established indication to PCI according to the guidelines of American Heart
             Association and American College of Cardiology;

          -  Native coronary lesion suitable for drug-eluting stent placement;

          -  True bifurcation lesions (Medina 0,1,1/1,1,1 /1,0,1);

          -  Reference vessel diameter in side branch ≥2.5mm by visual estimation;

          -  Complex bifurcation lesions based on DEFINITION study.

        Exclusion Criteria:

          -  Pregnancy and breast feeding mother;

          -  Co-morbidity with an estimated life expectancy of &lt; 50 % at 12 months;

          -  Scheduled major surgery in the next 12 months;

          -  Inability to follow the protocol and comply with follow-up requirements or any other
             reason that the investigator feels would place the patient at increased risk;

          -  Unable to provide written informed consent, or fail to follow the protocol;

          -  Previous enrolment in coronary intervention device investigation during the study
             period;

          -  Patient with STEMI within 24-hour from the onset of chest pain to admission;

          -  Restenosis bifurcation lesions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Shao-Liang Chen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Nanjing First Hospital, Nanjing Medical University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Shao-Liang Chen Chen, MD</last_name>
    <phone>+86-25-52208351</phone>
    <email>chmengx@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jing Kan, MBBS</last_name>
    <phone>+86-25-52208391</phone>
    <email>kanjingok@126.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Nanjing First Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaoliang Chen, MD</last_name>
      <phone>+86 13605157029</phone>
      <email>chmengx@126.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2017</verification_date>
  <lastchanged_date>February 9, 2017</lastchanged_date>
  <firstreceived_date>October 29, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nanjing First Hospital, Nanjing Medical University</investigator_affiliation>
    <investigator_full_name>Shaoliang Chen</investigator_full_name>
    <investigator_title>Vice President</investigator_title>
  </responsible_party>
  <keyword>Bifurcation lesion</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
